mothertobaby tirzepatide fact sheet pregnancy Wondering what the research has to say about the use of Tirzepatide and Pregnancy: Safety Facts – Metabolic dysfunction–associated steatotic liver disease

Lower the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type 2 diabetes and chronic kidney disease

Understanding how it compares to alternatives helps you determine if it is the right choice for your specific situation

Vegans need b12 supplementation regardless of medication use

Our weight loss providers will be with you every step of the way so you have a full support system during your journey

Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Half-Life 5 days Route of Administration : Subcutaneous injection Dosing Frequency : Once weekly Half-Life : ~5 days Formulation : Lyophilized powder for reconstitution Formulation & Handling Store at 20C Protect from light and moisture Reconstitute with sterile water

References 9 studies Tirzepatide Once Weekly for the Treatment of Obesity